Clinical Trials on Relapsing-Remitting

Total 886 results

Biogen

Completed

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (MOTION - JAPAN)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent Progressive

Japan
Abant Izzet Baysal University

Completed

Mental Rotation and Motor Imagery Training in Multiple Sclerosis

Relapsing Remitting MS (RRMS)

Turkey (Türkiye)
Rennes University Hospital

Recruiting

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis. (TRIO)

Multiple Sclerosis | Relapsing-remitting Multiple Sclerosis

France
Biogen

Completed

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (CONNECT)

Relapsing-Remitting Multiple Sclerosis

Israel, Hungary, Denmark, Italy, France, Czechia, Poland, Serbia, United Kingdom, United States, Spain, Belgium, Canada, Bulgaria, Sweden, Turkey (Türkiye), Germany, Kuwait
Judit Pich

Active, not recruiting

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis (TolDecCOMBINEM)

Relapsing-Remitting Multiple Sclerosis

Spain

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe